Sunflower Pharmaceutical appoints new senior management

Sunflower Pharmaceutical Group (SZSE:002737) announced the appointment of Yang Yang and Liu Guangtao as Deputy General Managers, effective immediately, following a board resolution passed on March 20, 2025. These appointments are intended to drive the company's "capital + industry" dual-engine strategy and enhance overall marketing performance. Yang, previously the General Manager of the company's Sales System, and Liu, formerly General Manager of Sunflower Pharmaceutical Group Medical Co., Ltd., will have terms aligned with the current board. Their compensation will align with the firm's senior management compensation policy. The announcement confirms that neither appointee holds company shares nor has conflicts of interest with major shareholders, executives or directors.